Browsing Tag
Celltrion
3 posts
Hikma and Celltrion sign exclusive licensing agreement for YuflymaTM for the Middle East and North Africa region
London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces an exclusive licensing agreement with…
July 18, 2022
Celltrion’s Monoclonal Antibody Treatment regdanvimab, Approved by EC
Celltrion Group announced today that the European Commission (EC) has approved Regkirona (regdanvimab, CT-P59), one of the first…
November 18, 2021
Celltrion Receives CHMP Positive Opinion for regdanvimab
Celltrion Group announced today that the European Medicine’s Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…
November 14, 2021